The Skin Health Institute is looking for adults aged 18 years and older with a clinical diagnosis of non segmental vitiligo for at least 3 months to participate in a clinical research trial and receive investigational oral treatment (active study drug) or placebo.  

Eligible participants must have body surface area (BSA) involvement of 4%-60% inclusive, and 0.5% or more involvement on the face.  Either active or stable disease non segmental vitiligo is accepted.  Individuals must agree to stop all other treatments for vitiligo from screening through the final follow-up visit. 

Participants will have regular visits with an experienced research team.  There is no cost to participate, and participants will be reimbursed for study-related expenses. 

Individuals will be asked to visit the study centre about 11 times over a period of about 60 weeks.